Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13365-020-00858-9 http://scihub22266oqcxt.onion/10.1007/s13365-020-00858-9 32529516!7288617!32529516     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Neurovirol 2020 ; 26 (4): 605-606 Nephropedia Template TP {{tp|p=32529516|t=2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 |pdf=|usr=}}{{32529516}} gab.com Text Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 JO: J Neurovirol http://www.kidney.de/pget.php?&tw=1&pmid=32529516 #FOAvip This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospinal fluid biomarkers, a diagnosis of Miller Fisher syndrome (MFS) was hypothesized and intravenous immunoglobulin therapy (IVIG) was initiated. Fourteen days after the start of IVIG treatment, the patient has been discharged at home with the resolution of respiratory symptoms and only minor hyporeflexia at the lower limbs, without any side effect. Twit Text FOAVip Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 ????J Neurovirol http://www.kidney.de/pget.php?&tw=1&pmid=32529516 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32529516 #FOAvip English Wikipedia <ref>{{Cite pmid|32529516}}</ref> Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 #MMPMID32529516 Manganotti P; Pesavento V; Buoite Stella A; Bonzi L; Campagnolo E; Bellavita G; Fabris B; Luzzati R J Neurovirol 2020[Aug]; 26 (4): 605-606 PMID32529516show ga This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospinal fluid biomarkers, a diagnosis of Miller Fisher syndrome (MFS) was hypothesized and intravenous immunoglobulin therapy (IVIG) was initiated. Fourteen days after the start of IVIG treatment, the patient has been discharged at home with the resolution of respiratory symptoms and only minor hyporeflexia at the lower limbs, without any side effect. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/*therapeutic use[MESH] |Middle Aged[MESH] |Miller Fisher Syndrome/*drug therapy/*virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH]Miller Fisher syndrome diagnosis and treatment in a patient with SARS-(epmc).pdf DeepDyve Pubget Overpricing